Charles River Labs Intl Stock
Price
Target price
€252.70
€252.70
1.690%
4.2
1.690%
-
15:37 / Tradegate
WKN: 939391 / Symbol: CRL / Name: Charles River Lb / Stock / Biotechnology & Medical Research / Mid Cap /
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.
Your prediction
Charles River Labs Intl Stock
There is an upward development for Charles River Labs Intl compared to yesterday, with an increase of €4.20 (1.690%).
Pros and Cons of Charles River Labs Intl in the next few years
Pros
?
B****
?
C******** o* t** e**********
?
G***** c******* t* c**********
Cons
?
W********* I********* f** t** n*** y****
?
S********** s********
?
M***** P*******
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Charles River Labs Intl vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Charles River Labs Intl | 1.690% | 0.648% | 26.721% | 84.690% | 43.933% | 35.792% | -31.354% |
| Ionis Pharmaceuticals Inc. | -0.920% | 6.074% | 9.420% | 42.693% | -23.426% | 45.566% | 60.568% |
| United Therapeutics | 0.530% | 2.118% | -3.162% | 68.513% | 6.085% | 114.631% | 166.647% |
| Novocure Ltd | 0.420% | 1.895% | 11.516% | 50.483% | 37.539% | -45.774% | -85.872% |
Comments
Charles River Laboratories International (CRL) had its "buy" rating reaffirmed by TD Cowen.
Show more
Ratings data for CRL provided by MarketBeat
Charles River Laboratories International (CRL) had its "overweight" rating reaffirmed by Morgan Stanley.
Show more
Ratings data for CRL provided by MarketBeat
Charles River Laboratories International (CRL) had its "overweight" rating reaffirmed by Barclays PLC.
Show more
Ratings data for CRL provided by MarketBeat
